In PAH, pulmonary vascular cells demonstrate increased aerobic glycolysis as a result of normoxic upregulation of HIF-1α and inhibition of pyruvate dehydrogenase. The gene discussed is HIF1A; the disease is pulmonary arterial hypertension.